Autoimmune hemolytic anemia (AIHA) is a well known complication of chronic lymphocytic leukemia (CLL). Steroids are the first line of treatment and there are limited effective treatment options for ...
An open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary biliary cirrhosis who had an incomplete response to the standard ursodeoxycholic ...
To address this issue better, the GITMO (Italian Group Bone Marrow Transplant) performed a retrospective study concerning the use of Rituximab in patients with refractory cGHVD. The results of this ...
Rituximab (Rituxan) may be a useful option for children with chronic steroid-dependent Henoch-Schonlein purpura, a small retrospective review suggested. Among eight children with this chronic ...
Phase II-I-II Study of Two Different Doses and Schedules of Pralatrexate, a High-Affinity Substrate for the Reduced Folate Carrier, in Patients With Relapsed or Refractory Lymphoma Reveals Marked ...
Please provide your email address to receive an email when new articles are posted on . Patients with pemphigus treated with rituximab had a longer disease-free survival than those treated with ...
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for ...
A retrospective analysis suggested that administering rituximab to patients with rheumatoid arthritis complicated by lymphoma, systemic vasculitis, or extra-articular lesions was associated with ...
Following implementation of low-dose rituximab as standard of care for muscle-specific kinase–positive myasthenia gravis (MuSK-MG), a hospital evaluated the treatment’s efficacy over a 2-year period.
Please provide your email address to receive an email when new articles are posted on . B-cell depletion with rituximab was safe and may be a potentially effective treatment for patients with systemic ...
Int J Clin Rheumatol. 2012;7(5):465-467. "[Although] excitement turned to disappointment when LUNAR did not show that rituximab did better than placebo … the LUNAR trial should not be viewed as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback